Telmisartan Mylan 40 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan mylan 40 mg tablets

mcdermott laboratories ltd., t/a gerard laboratories - telmisartan - tablet - 40 milligram(s) - angiotensin ii antagonists, plain; telmisartan

Telmisartan Mylan 20 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan mylan 20 mg tablets

mcdermott laboratories ltd., t/a gerard laboratories - telmisartan - tablet - 20 milligram(s) - angiotensin ii antagonists, plain; telmisartan

Telmisartan Fair-Med 20 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan fair-med 20 mg tablets

fair-med healthcare gmbh - telmisartan - tablet - 20 milligram(s) - angiotensin ii antagonists, plain; telmisartan

Telmisartan Fair-Med 40 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan fair-med 40 mg tablets

fair-med healthcare gmbh - telmisartan - tablet - 40 milligram(s) - angiotensin ii antagonists, plain; telmisartan

Telmisartan Fair-Med 80 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan fair-med 80 mg tablets

fair-med healthcare gmbh - telmisartan - tablet - 80 milligram(s) - angiotensin ii antagonists, plain; telmisartan

TELMISARTAN SANDOZ telmisartan 40mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan sandoz telmisartan 40mg tablet blister pack

sandoz pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; lactose; magnesium stearate; povidone; lactose monohydrate; crospovidone - telmisartan sandoz is indicated for treatment of hypertension, prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

TELMISARTAN SANDOZ telmisartan 80mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan sandoz telmisartan 80mg tablet blister pack

sandoz pty ltd - telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: meglumine; magnesium stearate; lactose; sodium hydroxide; povidone; lactose monohydrate; crospovidone - telmisartan sandoz is indicated for treatment of hypertension, prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

Telmisartan/Hydrochlorothiazide Liconsa 40 mg/12.5 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

telmisartan/hydrochlorothiazide liconsa 40 mg/12.5 mg tablets

laboratorios liconsa, s.a. - telmisartan; hydrochlorothiazide - tablet - 40 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; telmisartan and diuretics

Telmisartan GH telmisartan 80mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan gh telmisartan 80mg tablets blister pack

generic health pty ltd - telmisartan, quantity: 80 mg - tablet - excipient ingredients: sodium hydroxide; mannitol; magnesium stearate; sodium stearylfumarate; povidone; meglumine - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)

Telmisartan GH telmisartan 40mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

telmisartan gh telmisartan 40mg tablets blister pack

generic health pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: mannitol; meglumine; sodium hydroxide; povidone; sodium stearylfumarate; magnesium stearate - telmisartan gh is indicated for:,treatment of hypertension,prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials)